Targeting the CD47-SIRPα Axis in Atherosclerosis: From Pathogenesis to Therapeutic Implications
Journal of Inflammation Research · 2026-08 · Volume 19 · 1-20
DOI: 10.2147/jir.s605710 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Inflammation Research, 2026-08. Verfasst von ChangXin Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Clinical Medicine, Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
- State Key Laboratory of Traditional Chinese Medicine Syndrome/National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Science, Beijing, 100091, People's Repub…
- Department of Cardiology, Guang'an Men Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, People's Republic of China.
ORCID-Profile: ChangXin Sun
Zitieren
APA
Sun, C., Hu, L., Yuan, Y., Zhou, K., Wu, M., & Liu, L. (2026). Targeting the CD47-SIRPα Axis in Atherosclerosis: From Pathogenesis to Therapeutic Implications. Journal of Inflammation Research, Volume 19, 1-20. https://doi.org/10.2147/jir.s605710
Vancouver
Sun C, Hu L, Yuan Y, Zhou K, Wu M, Liu L. Targeting the CD47-SIRPα Axis in Atherosclerosis: From Pathogenesis to Therapeutic Implications. Journal of Inflammation Research. 2026;Volume 19:1-20. doi:10.2147/jir.s605710
BibTeX
@article{Sun2026,
author = {Sun, ChangXin and Hu, Lanqing and Yuan, Yongfang and Zhou, Kaidong and Wu, Min and Liu, Longtao},
title = {Targeting the CD47-SIRPα Axis in Atherosclerosis: From Pathogenesis to Therapeutic Implications},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--20},
doi = {10.2147/jir.s605710}
}
EUVIMED